PNQ-103-1

N/A

Report date: 2023/01/07 22:56:40
NME

Base Information

Drug NamePNQ-103-1
Drug Alias NamePNQ-103-1
ClassificationSmall molecules
Mechanisms of ActionAdenosine A2b receptor antagonists
TargetsAdenosine A2b receptor
Therapy Area/IndicationsAllergic asthmaPulmonary FibrosisColorectal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdvinus
China Registration ClassN/A

Develop Information

Active CompaniesAdvinus
Inactive CompaniesN/A
Active IndicationsAllergic asthmaPulmonary FibrosisColorectal Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A